Find out why the results may temper claims that recursive self-improvement is on the horizon. —Michelle Kim This summer has ...

Detailed price information for Recursion Pharmaceuticals Inc Cl A (RXRX-Q) from The Globe and Mail including charting and ...

Disc Medicine (IRON), and Recursion Pharmaceuticals (RXRX) are making meaningful pipeline progress, with key clinical and regulatory catalysts ahead in 2026, Morgan Stanley said in a note Monday.

Artificial intelligence (AI) is poised to reshape pharmaceutical research by addressing some of the industry's most ...

Recursion Pharmaceuticals' partnerships, notably with Genentech/Roche and Sanofi, have delivered $500M+ in milestone payments ...

Jack Clark, Anthropic’s co-founder, left on paternity leave last November. When he returned in February, he was surprised to ...

The CISCE has released the ISC Class 12 Computer Science syllabus for the 2026-27 board exam, emphasizing algorithmic problem-solving and future computing trends.It details theory on Boolean algebra, ...

Recursion Pharmaceuticals (NASDAQ:RXRX) outlined progress across its clinical pipeline, drug-discovery partnerships and AI-enabled research platform, while lowering its 2026 cash operating expense ...

We are no longer just discussing the potential of our platform." (CEO, President & Director Najat Khan) "We now have 5 clinical stage programs, including REC-4881 in FAP, where we have generated some ...

Detailed price information for Recursion Pharmaceuticals Inc Cl A (RXRX-Q) from The Globe and Mail including charting and trades.

Technology Technology   The Big Story AI giants back employee-led push to pace developmentAnthropic and OpenAI both backed an employee-led initiative asking the U.S.

Recursive, the AI research company led by Richard Socher, has signed a multi-year, $410 million agreement with Amazon Web Services (AMZN) to run its automated AI research system, putting the bulk of ...